Browsing byAuthor성종미

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 7 of 7

Issue DateTitleAuthor(s)Type
2020Comparison of heart failure risk and medical costs between patients with type 2 diabetes mellitus treated with dapagliflozin and dipeptidyl peptidase-4 inhibitors: a nationwide population-based cohort study성종미Article
2019Dipeptidyl peptidase-4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population-based cohort study곽혜선; 성종미Article
2019Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study곽혜선; 한혜원; 성종미Article
2020Efficacy and safety of clopidogrel versus prasugrel and ticagrelor for coronary artery disease treatment in patients with CYP2C19 LoF alleles: a systemic review and meta-analysis곽혜선; 성종미Review
2020Genotype-guided warfarin dosing may benefit patients with mechanical aortic valve replacements: randomized controlled study곽혜선; 성종미Article
2020Gonadotropin-releasing hormone agonists, anti-androgens and the risk of cardio-cerebrovascular disease in prostate cancer patients: an asian population-based observational study성종미Article
2021Risk of Cardiovascular Events and Medical Cost of Dapagliflozin and Dipeptidyl Peptidase-4 Inhibitors성종미Article

BROWSE